← Eichor
Study identifier: NCT06777420 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy

Condition: Breast Cancer Early Stage Breast Cancer (Stage 1-3) · Neoadjuvant Therapy · Shared Decision Making  ·  Sponsor: Region Örebro County

PhaseNA
Planned participants218
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Preoperative chemotherapy has been shown to be at least as effective as postoperative chemotherapy in breast cancer patients and has seen increased use over time. The decision regarding neoadjuvant treatment is complex, as various aspects need to be considered, and the patient's role in the decision-making process is central. The information provided by doctors to patients about preoperative treatment can be complicated, including details about treatment options, treatment plans, and side effects. If this information is not conveyed adequately, there is a risk of misunderstandings, which can lead to increased anxiety and stress for patients regarding their decisions. In oncology, question prompt lists (QPL) have been used as a tool to support patients by improving the information conveyed by doctors in various contexts where complex decisions need to be made. Studies have shown that QPL can facilitate better information exchange. However, their use in discussions about preoperative treatment for breast cancer patients has not been studied. Furthermore, evidence from randomized studies on the use of QPL in clinical practice is very limited. The aim of this study is to investigate whether the use of QPL during patient consultations involving discussions about neoadjuvant chemotherapy can improve information exchange in various aspects: understanding of the treatment; anxiety about the decision; participation in the decision-making process; patient-doctor communication; and d…

This description comes directly from the study's public registry record.

Talk to the study team

Antonios Valachis, MD, PhD  ·  +46 0196021792  ·  antonios.valachis@regionorebrolan.se

Servah Hosseini, MD

Always discuss trial participation with your own doctor first.

Locations (3)

Akademiska Uppsala University HospitalUppsala, Region Uppsala, SwedenNot Yet Recruiting
Västerås General HospitalVästerås, Region Västmanland, SwedenNot Yet Recruiting
Örebro University HospitalÖrebro, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06777420